AXP vs PRAX · P/E 20, rev $21.73B vs $7.38B cap
American Express Company (AXP) versus Praxis Precision Medicines Inc (PRAX) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported PRAX revenue for 2025-09-30 was $0. Net income was -$73.9M. PRAX currently screens at market cap $7.38B.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. PRAX currently screens at market cap $7.38B.
Not investment advice. Open the AXP and PRAX stock pages for the full models.
Not investment advice.